Suppr超能文献

小鼠红白血病细胞中可变珠蛋白链合成

Variable globin chain synthesis in mouse erythroleukemia cells.

作者信息

Alter B P, Goff S C

出版信息

Blood. 1978 Nov;52(5):1047-57.

PMID:279359
Abstract

Various mouse erythroleukemia cell lines show unique responses to chemical inducers. Lines 745 and 707, from DBA/2 mice, produced 25%--48% beta-minor and 78%--52% beta-major globin following culture with DMSO. Butyric acid treatment led to approximately 40% beta-minor globin, while induction with hemin resulted in over 80% beta-minor synthesis. Line FSD was developed independently. DMSO induction led to less than 10% beta-minor globin, while hemin and butyric acid both resulted in approximately 40% beta-minor synthesis. T3C12 and 5000 originated in DDD mice. With these lines all inducers led to only beta-major and no beta-minor synthesis. The inducers did not influence protein stability or initiation of globin synthesis. Translation of poly A-containing cytoplasmic RNA in a wheat germ cell-free system led to proportions of beta-minor that were the same as those seen in the intact cells. Thus regulation of the type of globin chain produced in erythroleukemia cells following culture with several inducing agents occurs at either the level of gene transcription or posttranslational processing, or by growth of a selected cell population.

摘要

各种小鼠红白血病细胞系对化学诱导剂表现出独特的反应。来自DBA/2小鼠的745和707细胞系,在用二甲基亚砜(DMSO)培养后,产生了25%--48%的β-珠蛋白 minor和78%--52%的β-珠蛋白major。丁酸处理导致约40%的β-珠蛋白minor,而用血红素诱导则导致超过80%的β-珠蛋白minor合成。FSD细胞系是独立开发的。DMSO诱导导致β-珠蛋白minor不到10%,而血红素和丁酸均导致约40%的β-珠蛋白minor合成。T3C12和5000起源于DDD小鼠。对于这些细胞系,所有诱导剂仅导致β-珠蛋白major合成,而无β-珠蛋白minor合成。诱导剂不影响蛋白质稳定性或珠蛋白合成的起始。在小麦胚无细胞系统中翻译含多聚A的细胞质RNA,导致β-珠蛋白minor的比例与完整细胞中所见相同。因此,在用几种诱导剂培养后,红白血病细胞中产生的珠蛋白链类型的调节发生在基因转录水平、翻译后加工水平,或通过选择细胞群体的生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验